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There is a need to support individuals with Duchenne Muscular Dystrophy (DMD) to
achieve optimal functionality in everyday life and with meaningful tasks and activities,
throughout stages of the disease progression. Thus, technological developments have
created an exciting opportunity for the use of affordable virtual reality (VR) systems with
different kinds of interaction devices, providing an efficient and fun tool for enabling
improvement in motor performance.
Objective: To compare performance on a virtual task using interfaces with and without
physical contact in order to identify functionality by using different devices in individuals
with DMD.
Methods: One hundred and twenty male individuals took part on this study: 60 with
DMDwith a mean age of 16± 5 (range 9–34 years old) and 60 without DMD in the control
group (CG) matched by age. Participants were divided into three groups of 20 individuals
each which performed a virtual task in three different interfaces: Kinect®, computer
Touch Screen and Leap Motion®, in a cross over design in which all participants used all
devices. Motor impairment in the DMD group was measured by using the Motor Function
Measurement and Vignos scales.
Results: All participants improved performance through practice, regardless of the
interface used, although the DMD group had a continuous lower performance compared
to the CG. In addition, the DMD group obtained a significant better performance with
Leap Motion interface compared to the other interfaces, while the CG presented better
performance on Touch Screen interface.
de Freitas et al. Virtual Reality in Duchenne Muscular Dystrophy
Conclusion: Leap Motion provided better performance for individuals with DMD due
to enablement of distal muscle function and ease of instrument adjustment using the
virtual interface. Therefore, this type of interface should be encouraged for promoting
functionality on general tasks using computer systems. Clinical Trial register number:
NCT02891434.
Keywords: Duchenne Muscular Dystrophy, learning, motor skills, virtual reality exposure therapy, virtual reality,
computer storage devices, functionality
INTRODUCTION
Duchenne Muscular Dystrophy (DMD) is an inherited recessive
genetic disease characterized by the absence of dystrophin
protein in muscle fiber membrane resulting from a mutation
of the Xp21 gene (1), and has an incidence of ∼1 in every
3,500 males (2). DMD is characterized by the progressive and
irreversible weakening of muscles that leads to severe physical
disability (3). The initial clinical manifestations are muscle
weakness of the pelvic and scapular girdles, and muscular
contractures and retractions which results in difficulty in
walking and other functional activities (4). Individuals with
DMD become increasingly dependent on caregivers for daily
activities, thus requiring more assistance and care overtime
(5, 6). Therefore, there is a need to support individuals with
DMD to achieve optimal functionality in everyday life and with
meaningful tasks and activities, throughout stages of the disease
progression.
Technological developments have created an exciting
opportunity for the use of assistive technology for rehabilitation
activities through ubiquitous and affordable virtual reality (VR)
systems providing a dynamic, enabling, and fun interaction
platform (7, 8). For example, computer games were used in
the training of respiratory muscles during various stages of
disease progression in 15 males with DMD to successfully engage
and improve respiratory performance in participants who had
moderate impairment in lung function tests (9). Also, a new
technique for functional assessment of upper limbs through
exercises in virtual environment was evaluated, and results
showed that the VR simulator had the ability to assess strength
capacity in patients with DMD (10).
A study by Massetti et al. (11) evaluated 22 individuals
with DMD to identify whether practicing a task in a virtual
environment could improve performance by comparing to a
similar task in a real environment, in addition to distinguishing
whether there was transference between environments.
They concluded that both virtual and real tasks promoted
improvement in performance in the acquisition phase, short-
term retention, and transfer phase. However, there was
no transfer of learning between environments. Although a
functional task was not used, the use of virtual environments
for individuals with DMD should be considered carefully
when the aim is to transfer motor ability from virtual to real
environment (11).
In addition to the possibility of using VR in treatment
programs to enable improvements in day-to-day tasks, it is
important to identify interaction devices that exist in the market
that better enable functionality for individuals with DMD to
interact with the virtual environment. Individuals with DMD
present preservation of the strength of musculature of the
upper extremities for longer than in lower extremities, especially
distal muscles such as the flexors of the fingers (12). Therefore,
adaptations using VR can be used to support functional
independence for a longer time period (13) providing various
types of interfaces for rehabilitation, and can keep patients
engaged with VR tasks. However, no studies have systematically
investigated performance using VR nor actual interface devices
for individuals with DMD.
Studies illustrated that different interaction devices for the
same task could provide a number of significant results (14–16).
For instance, using a device such as webcam, Kinect or Leap
Motion, provides abstract information (without physical contact)
and can result in different performance results compared to the
same task performed using a Touch Screen, mouse or computer
keyboard that offer more tangible information with physical
contact (14, 15). Thus, the aims of the present study were to
compare the difference between three interaction devices which
may enable improved performance in the execution of virtual
tasks in individuals with DMD. Also, to identify if the motor
ability acquired with practice on non-contact devices (more
virtual, represented by Microsoft’s Kinect for Windows and Leap
Motion—LMCH, Leap Motion, Inc., San Francisco, CA) would
be transferred to contact devices (more real, represented by the
Touch Screen) and vice-versa. We also compared differences
between DMD and a control group (CG) of healthy individuals
after practicing the same task using the different devices.
We hypothesized that non-contact devices would result in
worse performance compared to contact devices for both groups
as they are typically more difficult to use considering that
they have no tactile feedback (11). However, as supposed by
Massetti et al. (11), the virtual task (non-contact devices) which is
relatively new and more difficult for the participants, will enable
an experience that provides new adaptations and motor engrams
during acquisition, and is considered beneficial for providing
better transfer of performance to a real environment situation
(or an environment with more real life characteristics such as
a Touch Screen that provides tactile feedback); with the CG
predicted to have better performance for all interfaces (17, 18).
If this hypothesis is correct, results will provide practical benefits
in helping health professionals to use the best devices on VR
to enable individuals with DMD to be more functional and
independent as the disease progresses.
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METHODS
This was a randomized repeated exposure controlled trial
and was approved by the Ethics Committee for review of
research projects of the School of Medicine, University of São
Paulo (FMUSP), under protocol number 248/15 and registered
at Clinical Trials under register number NCT02891434. The
participants and/or the legal guardians of the children under the
age of 18 years old provided written informed consent.
Participants
A total of 120 individuals took part in this study, 60 with DMD
andwere recruited through the Brazilian Association ofMuscular
Dystrophy (ABDIM)—(age 16 ± 5 years old, ranging between 9
and 34 years old) and 60 healthy males for the Control Group
(CG), matched by age (age 16 ± 5 years old, ranging between 9
and 34 years old).
The inclusion criteria for the DMD group were a confirmed
diagnosis of DMD. Those in the CG were males without any
neuromuscular conditions. Exclusion criteria for participants
were: not capable of performing the virtual task after one test-
trial, in which we assessed the comprehension of the task by
assessing performance in this single trial (verbal and written
instructions were provided before the experiment), or presence
of upper limb deformity or muscle weakness that prevented
handling of the devices used in this study. However, no
participant was excluded based on these criteria.
To describe and characterize motor impairments in the DMD
group, the Motor Function Measure (MFM) scale was used (19).
The scale is subdivided into three dimensions: dimension 1 (D1)
standing position and transfers (13 items); dimension 2 (D2)
axial and proximal limb motor function (12 items); dimension 3
(D3) distal limb motor function (7 items). Items are scored from
zero to three with a total percentage value obtained by adding
all section percentage totals (20). To describe the staging of the
disease the Vignos scale was administered with a score of 1–10,
and a higher value equating to more severe disease (21, 22).
Instruments
After providing instructions for the interventions, participants
performed the task individually in a quiet room with only the
experimenter present. The computer and monitor were placed
on a flat table. The participants were seated on a chair (ambulant)
or seated in their own wheelchair, which was adjusted to height
according to the needs of the individual. The experimenter
explained and demonstrated the task and participants were
FIGURE 1 | Graphic representation of an individual with DMD using the Touch Screen interface. (A) initial screen of the task, with 126 bubbles; (B) participant defines
the area of the range zone by touching the screen for 10 s; (C) participant touches the first target bubble (defined by the researcher in the center of the bottom line of
the range zone); (D) participant touches a bubble that appears at random (within the range zone); (E) participant returns to touch the target bubble; (F) some touches
of the bubble are outside of the range zone, challenging the limits of the participant; (G) individual with Duchenne Muscular Dystrophy (DMD) during the task using the
touch screen interface.
Frontiers in Neurology | www.frontiersin.org 3 January 2019 | Volume 10 | Article 24
de Freitas et al. Virtual Reality in Duchenne Muscular Dystrophy
FIGURE 2 | Graphic representation of an individual with DMD using the Kinect interface. (A) initial screen of the task, with 126 bubbles; (B) participant defines the
area of the range zone for 10 s; (C) participant touches the first target bubble (defined by the researcher in the center of the bottom line of the range zone); (D)
participant touches a bubble that appears at random (within the range zone); (E) participant returns to touch the target bubble; (F) some touches of the bubble are
outside of the range zone, challenging the limits of the participant; (G) individual with Duchenne Muscular Dystrophy (DMD) during the task, using the Kinect interface.
Some participants needed to support the upper limb on the arm of the wheelchair.
instructed to place the preferred hand (i.e., the less affected hand)
with all three interfaces in a random order.
To evaluate the performance of the interaction devices,
we used a computer game proposed by the Department of
Information Systems, University of São Paulo (23). The game
was chosen due to its low cognitive demands and ease and
adaptability for use in individuals with DMD.
Three interfaces were investigated, two without physical
contact and one with physical contact. The first of these was
represented by Kinect for Windows (Microsoft, Redmond WA,
USA), which consists of a sensor that captures body movements
(including upper limbs) (24). The second non-physical contact
interface was Leap Motion (LMCH, Leap Motion, Inc., San
Francisco, CA, USA), a virtual interface by means of a sensor and
its catchment area is focused only on hands and fingers (29). The
third interface, requiring physical contact, was a Touch Screen
monitor on the computer screen itself (23).
The computer game presents 126 bubbles arranged in rows
and columns (Figures 1A, 2A, 3A). Participants must attempt to
change the color of the largest number of bubbles in 10 s, thereby
defining a range zone (Figures 1B, 2B, 3B).
After defining the range zone, the therapist established a red
target bubble, which was chosen in the center of the bottom
line of the range zone (Figures 1C, 2C, 3C). After touching the
target bubble, the game had another red bubble in a random
position, within the area of the range zone (Figures 1D, 2D,
3D). After reaching the second bubble, the bubble target was
displayed again in another location, and so on (Figures 1E,
2E, 3E). The game features red bubbles within the area of the
range zone (Figures 1E, 2E, 3E), and sometimes out of this zone
(Figures 1F, 2F, 3F), thus creating a higher degree of difficulty
and encouraging participants to challenge their limits (23), using
touch screen (Figure 1G), Kinect (Figure 2G) or LeapMotion
interface (Figure 3G).
Procedure and Design
During performance using the Leap Motion sensor, a wedge
to support the handle was used leaving a required distance for
capturing the movement of the fingers. For the Kinect interface,
some participants needed support for the upper limb on the arm
of the wheelchair. This was done due to individuals with DMD
needing to sustain the upper limb for an extended time, which
can lead to muscle fatigue and consequently can decrease the
performance on the task.
In order to assess the performance of individuals from both
groups for each device, a short-term motor learning design was
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FIGURE 3 | Graphic representation of an individual with DMD using the Leap Motion interface. (A) initial screen of the task, with 126 bubbles; (B) participant defines
the area of the range zone for 10 s; (C) participant touches the first target bubble (defined by the researcher in the center of the bottom line of the range zone); (D)
participant touches a bubble that appears at random (within the range zone); (E) participant returns to the bubble target; (F) some touches of a bubble are outside of
the range zone, challenging the limits of the participant; (G) individual with Duchenne Muscular Dystrophy (DMD) during the task, using the Leap Motion interface
(when necessary a wedge was used to adapt the lifting of the handle).
carried out. This considered three phases: acquisition in which
the participants practiced the task with enough attempts to
improve performance, in addition to assessing the capacity to
retain the improvement acquired after a period with no contact
with the task (retention test). It was also determined if the
participant would maintain their performance when changing
some characteristics of the task (transfer test) (25). Thus, all
participants performed the same task in four stages in a cross-
sectional design: acquisition (enough attempts to reach 150
bubbles), retention (one attempt after 5min with no contact
with the task) and transfer (transfer 1 and 2—one attempt in
each device that was not used in the acquisition, see Figure 4).
The entire trial took approximately 30min. In this randomized
cross over trial the participants (DMD and CG) were randomly
allocated to 1 of 3 groups: Group A, which underwent acquisition
and retention using the Touch Screen interface with transfers
onto the Leap Motion and Kinect interfaces, respectively; Group
B, which underwent acquisition and retention using the Kinect
interface with transfers on the Touch Screen and Leap Motion
interfaces, respectively; Group C: which underwent acquisition
and retention using the Leap Motion interface with transfers on
the Touch Screen and Kinect, respectively (Figure 4).
All participants performed the task with all interfaces.
Data Analysis
A one-way ANOVAwas performed on the difference in the mean
scores for the functional scales (MFM-D1, MFM-D2, MFM-D3,
MFM-tot, Vignos) and age for the DMD group, to attest the
homogeneity of the sample within groups of interfaces (Table 1).
The number of bubbles reached was considered the dependent
variable and was submitted to a 2 (group: DMD, CG) by 3
(Interfaces: Kinect, Touch Screen, Leap Motion) by 2 (Attempt)
ANOVA, with repeated measures on the last factor. For the
factor Attempt, separate comparisons were made for acquisition
(first acquisition attempt—FA vs. last acquisition attempt—
LA), retention-R (LA vs. retention attempt—R) and transfer-T
(R vs. transfer attempt T1, R vs. transfer attempt T2). Post-
hoc comparisons were carried out using Tukey-LSD (Least
Significance Difference). Partial eta-squared (ηp²) was reported
to measure effect size and was interpreted as small (effect
size >0.01), medium (effect size >0.06), or large (effect size
>0.14) (26).
Regression analysis was performed to determine if factors
including age, MFM-D1, MFM-D2, MFM-D3, MFM-total, and
Vignos influenced performance during the practice test for the
DMD group, considering improvement in number of bubbles
touched (BT) from the first to final practice blocks (difference
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FIGURE 4 | Outline of the experimental and control groups during the phases of acquisition, retention and transfer, and their interfaces. Abbreviations: n, number of
participants; DMD, Duchenne muscular Dystrophy; CG, control group.
LA-FA). The software used was SPSS, 20.0. Significance was set
at p < 0.05.
RESULTS
Demographics of the DMD group including age and functional
scale score are described in Table 1, showing the homogeneity
within groups of interface. Table 2 shows the number of
individuals in each item on the Vignos scale.
Acquisition
For acquisition we compared first acquisition attempt—FA
with the last acquisition attempt—LA, in order to discover
improvements by considering the amount of bubbles reached
during practice.
Significant effects were found for Attempt, [F(1, 114) =
20.8, p < 0.001, ηp
2
= 0.15, Group, F(1, 114) = 92.6, p
< 0.001, ηp
2
= 0.45, but not for Interface F(2, 114) = 2.3,
p > 0.05, η2p = 0.04]. Therefore, both groups increased
the number of BT from First Attempt (FA) (M = 70)
to Last Attempt (LA) (M = 78). The DMD group had
worse performance (M = 57) when compared to CG (M
= 91). Interaction for group by interface [F(2, 114) = 7.4,
p = 0.001, ηp
2
= 0.12] was found indicating a difference
between the DMD and CG with DMD performing worse on
all interfaces, on Touch Screen (M = 105 and 52, respectively),
Leap Motion (M = 86 and 62, respectively), and Kinect (M
= 81 and 57, respectively). The results are represented in
Figure 5.
In the CG, the performance was better for Touch Screen (M
= 105) when compared to Leap Motion (M = 86) and Kinect
(M = 81), with no difference between Kinect and Leap Motion.
In DMD group, the performance was worse on Touch Screen (M
= 50) when compared to Kinect (M = 54) and Leap Motion (M
= 62). In addition, the post-hoc test also showed that the DMD
group had a better performance in the LA block on Leap Motion
(M = 67) compared to the Kinect (M = 54) and Touch Screen
(M = 54). For the CG there was no difference between interfaces
in the different blocks.
Retention
The last acquisition attempt was compared—LA vs. Retention—
R, to assess the short-term retention of performance acquired
with practice, after a 5min break with no contact with the task.
Significant effects were found for Attempt, [F(1, 114) = 15.4,
p < 0.001, ηp
2
= 0.12, Group, F(1, 114) = 90.1, p < 0.001, ηp
2
= 0.44, and Interface F(2, 114) = 4.2, p = 0.0017, ηp
2
= 0.07].
Similarly to the acquisition phase, these results suggest that the
participants increased the number of BT from Last Attempt (LA)
(M = 78) to Retention (R) (M = 83), with CG showing better
performance (M = 97) when compared to the DMD group (M =
62). In addition, interaction for group by interface [F(2, 114) = 7.3,
p= 0.001, ηp
2
= 0.11] was found meaning that the CG presented
better performance compared to the DMD group in all interfaces:
on Touch Screen (M= 109 and 56, respectively), on LeapMotion
(M = 94 and 74, respectively) and on Kinect (M = 87 and 56,
respectively). Post hoc analysis found a significant difference for
the DMD group from LA to R on Leap Motion (M = 67 and 81,
respectively).
Transfer 1
For transfer 1 and 2, comparisons were made between Retention-
R vs. Transfer 1, and R vs. Transfer 2, to assess the transfer of
performance to different types of interaction devices.
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TABLE 1 | Mean and standard deviations of the groups in each functional scale scores category.
Age Vignos MFM-D1 MFM-D2 MFM-D3 MFM-Tot
Gr n M (SD) M (SD) M (SD) M (SD) M (SD) M (SD)
K 20 15.9 (5.6) 6.1 (2.2) 17.7 (26.7) 59.3 (29.8) 84.1 (10.6) 54.6 (18.4)
LM 20 17.0 (4.7) 6.2 (2.5) 15.4 (23.7) 59.7 (24.3) 78.3 (17.3) 61.0 (23.7)
TS 20 17.4 (4.6) 6.3 (2.5) 13.1 (22.4) 60.1 (27.1) 72.5 (24.1) 47.6 (21.7)
p 0.64 0.97 0.86 0.99 0.21 0.18
Total 16.65 (4.90) 6.23 (2.32) 15.23 (23.9) 61.05 (30.7) 78.06 (18.8) 54.38 (21.9)
Min/Max 9/34 1/8 0/74 0/100 19.5/100 13.54/87.5
In addition, the p-value of one-way ANOVA within groups of interfaces. Gr, group; K, Kinect; LM, Leap Motion; TS, Touch Screen; n, number of participants; M, mean; SD, standard
deviation; MFM, Motor Function Measure; MFM-D1, first domain score of the MFM scale; MFM-D2, second domain score of the MFM scale; MFM-D3, third domain score of the MFM
scale; MFM-Tot, total domain score of the MFM scale; Min, minimum; Max, Maximum.
TABLE 2 | Classification of the level of severity of Duchenne Muscular Dystrophy (DMD) using the Vignos scale, within groups of Interfaces and total.
Vignos scale Number of individuals
K LM TS Total
1 Walks and climbs stairs without assistance 1 1 1 3
2 Walks and climbs stairs with aid of railing 1 2 2 5
3 Walks and climbs stairs slowly with aid of railing (over 25 s for 8 standard steps) 1 1 1 3
4 Walks unassisted and rises from chair but cannot climb stairs 0 0 0 0
5 Walks unassisted but cannot rise from chair or climb stairs 0 1 0 1
6 Walks only with assistance or walks independently with long leg braces 2 0 0 2
7 Walks in long leg brace but requires assistance for balance 8 5 6 19
8 Stands in long leg brace but enable to walk even with assistance 3 8 8 21
9 Is in a wheelchair 0 0 0 0
10 Is confined to a bed 0 0 0 0
n = 54, because six of them had not Vignos scores.
FIGURE 5 | Number of bubbles touched by Duchenne Muscular Dystrophy (DMD) and the control group (CG) during the stages of motor learning.
Significant effects were found for Attempt, [F(1, 114) = 11.8,
p = 0.001, ηp
2
= 0.09 and Group, F(1, 114) = 67.0, p < 0.001,
ηp
2
= 0.37]. These results suggest that the participants decreased
the number of BT from R (M = 83.2) to T1 (M = 74.7),
and the CG had a larger number of BT (M = 94) compared
to the DMD group (M = 64). Interaction for attempts by
interface, [F(2, 114) = 5.1, p = 0.007, ηp
2
= 0.01], was found.
Post-hoc analysis showed that both groups (DMD and CG) that
performed the acquisition and retention phases on Touch Screen
(RetentionM = 86) decreased performance on transfer for Leap
Motion (M = 68). There was no significant difference between
acquisition/retention on LeapMotion (M= 88.2) and transfer for
Touch Screen (M = 80), nor for acquisition/retention on Kinect
(M = 75) and transfer for Touch Screen (M = 76). Considering
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the performance for each group, in the CG group alone there
was difference in acquisition/retention on Touch Screen (M =
112) and with worse performance on transfer on Leap Motion
(M = 76), and in the DMD group there was difference in
acquisition/retention performance on Leap Motion (M = 81)
with worse performance for transfer on Touch Screen (M = 59).
Transfer 2
Significant effects were found for Attempt, [F(1, 113) = 30.7, p <
0.001, ηp
2
= 0.21, and Group, F(1, 113) = 55.2, p < 0.001, ηp
2
= 0.33]. These results suggest that the participants decreased
the number of BT from R (M = 83) to T2 (M = 71). The CG
group had a larger number of BT (M = 90) than the DMD
group (M = 64). Interaction for attempts by group, [F(1, 113) =
6.1, p = 0.015, ηp
2
= 0.05], attempts by interface, [F(2, 113) =
4.5, p = 0.013, ηp
2
= 0.07], and group by interface, [F(2, 113)
= 4.2, p = 0.017, ηp
2
= 0.07, were found. Post-hoc analysis
showed that both groups that performed the acquisition and
retention phases on Touch Screen (RetentionM = 86) decreased
performance on transfer for Kinect (M = 68). Additionally, there
was significant difference between acquisition/retention on Leap
Motion (RetentionM= 88) and transfer for Kinect (M= 73), but
there was no significant difference between acquisition/retention
on Kinect (Retention M = 76) and transfer for Leap Motion (M
= 73).
Regression Analysis
The regression analysis revealed that the scores of the Vignos
(positively related) and MFM-D2 (inversely related) scales
predicted the improvement of performance in the DMD group,
while age, MFM-D1, MFM-D3, and MFM total did not [F3, 26
= 3.65, p = 0.025, r2 = 0.30], equation: Improvement = 26.1
∗Vignos,−0.857 ∗MFM-D2].
DISCUSSION
This study found that people with DMD benefitted from the
use of virtual technologies as compared to touch interfaces in
acquisition and retention of performance during tasks. Contrary
to what we hypothesized that non-contact devices would result
in worse performance compared to contact device, the results
demonstrate that in individuals with difficulty in moving the
upper limbs, there is an improvement in performance when
using the Leap Motion interface that enabled distal muscle
functioning and ease of instrument adjustment for individuals
with DMD. This result is supported by Massetti et al. (11) who
demonstrated that individuals with DMD are able to learn new
tasks in real and virtual environments and are able to retain and
transfer the performance. Our findings suggest that interfaces
with no physical contact may offer an exciting opportunity to
support independent functioning across a number of meaningful
activities in this group. As independent functioning, we can
speculate that Leap Motion or similar devices can be used with
computers to allow interaction and socializing with others, and
also to do routine tasks such as internet banking, study, watching
TV and in future, virtual movements can be used to control a
wheelchair. There is a need to further explore the use of VR for
people with DMD and other disorders in which movement is
affected, in order to determine strategies for optimal functioning
for individuals and throughout stages of disease progression.
During the acquisition phase, regardless of the interface
used, there was improvement in task performance with practice,
comparing the first attempt (FA) to the Last Attempt (LA) for
both groups, and also in the retention phase—in which the
participants increased the number of the bubbles reached from
the Last Attempt (LA) to the Retention (R). We observed that
practice improved performance possibly due to improvements in
quality and organization of movement (14).
Despite the improved performance in the acquisition and
retention phase in both groups, the DMD group had worse
performance in the acquisition phase and in the retention
phase when compared to CG. Malheiros et al. (18) used a
computer maze task and found similar results, demonstrating
that despite its ability to improve performance in a motor task
on the computer, individuals with DMD had impaired functional
performance compared to CG. Nakafuji and Tsuji (27) and
Cyrulnik et al. (28), observed improvement in the learning
curve, with the DMD group consistently having slightly worse
performance than the CG. The difficulties of individuals with
DMD compared to the CG could be due to the deficit, both
in adaptive functioning measures, such as cognition, receptive
and expressive language, visual-spatial skills, fine motor skills,
attention and memory (28).
Regarding performance on each device in the acquisition
and retention phases, the best performance in the DMD group
was using the Leap Motion interface. Considering the typical
preservation of wrist and finger functional capacity which
lasts for a longer time period in DMD compared with other
limb functions (12), the Leap Motion technology offered better
utilization of these distal movements and thereby justifies its use
as an interface for enhancing functionality in DMD. The findings
support that alternative technologies may offer more optimal
solutions compared to standard rehabilitation techniques. The
Leap Motion capture by fine movements of the hand joints may
be a suitable tool for providing thin manual functions (29, 30).
As hypothesized, we found that performance in the CG was
best when using the touch screen interface and therefore they
benefited from the possibility of haptic information and response
speed offered by the Touch Screen. A task that involves a direct
interaction with the environment, including physical contact
(more real task) provides a richer set of information to guide
the movement compared to a more abstract task without physical
contact (more virtual task) (15).
Individuals with DMD have weakness in segments such as
shoulders and elbows, which hinder the movement of pronation
and supination of the forearm, in addition to the radial and
ulnar deviation (31–33). We can only speculate that these
conditions hinder performance at the interface with touch screen,
which requires greater power and control of the proximal trunk
muscles (30).
Finally, considering the transfer phase, all participants had
worse performance regardless of the interface used. When
the CG started the task using the interface with physical
contact and transferred to non-contact (Leap Motion), there
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was deterioration in performance. Again, the difficulty in
accomplishing the task without the benefits of physical contact
is probably responsible for the lower performance in the Leap
Motion interface. However, in the DMD group the results
were opposite, and there was a decrease in performance when
transferring to a more real environment feature (Touch Screen).
This was previously observed by Monteiro et al. (15) who
found that practice in virtual interfaces resulted in a decline
in performance when transferring to environments with Touch
Screen interfaces.
Another important finding was that age did not influence the
learning effects for the gaming task. Such results corroborate with
the findings of Malheiros et al. (18), in which age also did not
influence performance in a computer task in the DMD group.
This is an unexpected result as the disease progress and motor
function deteriorate with age.
Furthermore, while exploring the relationship between motor
function and performance, no relationship was found between
the functionality of the hands (Dimension D3 of MFM) and
performance. Mattar and Sobreira (34) indicated that the
strength of the hands in individuals with DMD decreases with
age and is significantly different compared to the typically
developing adults. However, as our sample was composed
mostly of adolescents who had good scores on the MFM-D3
(around 80%—Table 1), we can speculate that there was not
enough impairment in distal function that could influence the
performance on the task. Possibly the VR interface acted to
equalize deficits and thus shows the promise for VR interfaces
such as the Leap Motion to enable functioning in conditions
such as DMD. In addition, we also found that trunk motor skills
(Dimension D1 of MFM) did not influence performance in any
of the tasks. Controversy, the study by Capelini et al. (17) showed
that trunk functionality influenced performance on a virtual
task using a Smartphone i.e., individuals with lower scores on
functionality performed worse on the task. However, individuals
in the study by Capelini et al. (17) presented a lower mean score
of MFM-D1 (∼12%), compared to the current population of
DMD (∼15%).
Nonetheless, we do report a relationship between a greater
difference between LA and FA (higher learning curve) and the
higher score on the Vignos scale and lower score on Dimension
D2 of MFM. This means that individuals with more severe motor
impairment and lower proximal musculature motor skills had
greater capacity to adapt to the task and tended to have greater
learning, which may be due to the fact they started with lower
scores.
A limitation of the study was that the data was not
extrapolated to function in daily life activities, and we used
only one specific game to verify the performance on three
different devices. Another limitation is the fact that we have
not evaluated usability or compliance of individuals, in order
to clarify engagement and the influence of their judgement in
the performance of the task. As we have found positive results
regarding Leap Motion, we suggest that future studies should use
different tasks and/or games to assess performance, as well as use
scales to assess usability and compliance to provide explanations
regarding function in every day use.
CONCLUSION
The results showed an improvement in performance when
using a virtual interface requiring no physical contact for
individuals with DMD, despite the progressive difficulty in
movement and strength of the upper limbs. A key factor in the
rehabilitation and care of individuals with DMD is to identify
ways to facilitate performance in activities of daily living and
to encourage the development and maintenance of motor skills
with emphasis on upper limbs (4). Thus, a device with no contact
(Leap Motion) facilitated the successful implementation of the
proposed task, which provides evidence for future research using
virtual interfaces which encourage distal movement and have the
potential allow for improvements in daily tasks for individuals
with DMD.
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